Zinc Oxide
Key facts at a glance
- ATC
- D02AB01
- RxNorm
- 11477
- Generic
- Zinc Oxide
- Class
- unclassified
- Brands
- Lantiseptic Multi-Purpose, Manzatin-E, Baza-Protect, Flanders, Risamine, PeriGuard, Rash Relief Antibacterial, Rash Relief Antifungal, Macuvite with Lutein, Tronolane Anesthetic, Rash Relief with Zinc Oxide, Calmol, A+D Diaper Rash, Vitafol-One, NicAzel
- Availability
- otc
- Pregnancy
- C
- Lactation
- safe
- Half-life (h)
- 0
- Onset (min)
- 0
- Duration (h)
- 0
- Routes
- topical, oral, rectal
- Forms
- cream, ointment, paste, lotion, powder, stick, tablet, capsule, softgel, suppository
- Regions
- United States, Canada, European Union, United Kingdom, Australia, Japan, Brazil, India, worldwide
- Monitoring
- none for topical use, serum zinc levels with prolonged high-dose oral administration
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy